No Statistically Apparent Difference in Antifungal Effectiveness Observed Among Trimethoprim/Sulfamethoxazole Plus Clindamycin or Caspofungin, and Trimethoprim/Sulfamethoxazole Monotherapy in HIV-Infected Patients with Moderate to Severe Pneumocystis Pneumonia: Results of an Observational Multicenter Cohort Study.
Infect Dis Ther
; 11(1): 543-557, 2022 Feb.
Article
em En
| MEDLINE
| ID: mdl-35050490
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Clinical_trials
/
Etiology_studies
/
Observational_studies
Idioma:
En
Revista:
Infect Dis Ther
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
China